| PACKAGING TYPE: | 10x10 Tablets In C-box |
| COMPOSITION: | Telmisartan 40 Mg & Chlorthalidone 6.25 Mg |
| FORMULATION: | Tablets |
| Description: | TELOSAF-CT 40/6.25 Tablet is a combination of Telmisartan 40 mg and Chlorthalidone 6.25 mg. It is used for the management of hypertension (high blood pressure) in patients who require combination therapy. Telmisartan relaxes blood vessels by blocking angiotensin II receptors, while Chlorthalidone helps remove excess fluid and salt from the body, enhancing blood pressure control. |
| Side Effects: | Common: Dizziness or lightheadedness Increased urination Fatigue Mild electrolyte imbalance Serious (Rare): Severe hypotension Electrolyte disturbances (low potassium or sodium levels) Kidney function impairment Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take as prescribed by a healthcare professional Usually administered once daily, with or without food Swallow the tablet whole with water Do not alter the dose without medical advice |
| Precaution: | Monitor blood pressure and electrolyte levels regularly Use with caution in patients with kidney or liver disorders Avoid use during pregnancy Inform your doctor about all medications being taken Maintain adequate hydration during treatment |
| Product Benefits: | Provides effective control of high blood pressure Dual mechanism improves antihypertensive efficacy Reduces risk of cardiovascular complications such as stroke and heart attack Promotes fluid balance by eliminating excess sodium and water Suitable for |
| Expiry Date: | 2028-01-31 |
Frequently Asked Questions
It is used to manage hypertension (high blood pressure) and reduce the risk of cardiovascular complications.
Yes, increased urination and mild dizziness are common due to its diuretic effect.
Yes, under medical supervision with regular monitoring of blood pressure and electrolyte levels.










